Cape Investment Advisory’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77K | Hold |
350
| – | – | ﹤0.01% | 963 |
|
|
2025
Q1 | $1.85K | Sell |
350
-154
| -31% | -$815 | ﹤0.01% | 904 |
|
|
2024
Q4 | $3.41K | Buy |
504
+154
| +44% | +$1.04K | ﹤0.01% | 813 |
|
|
2024
Q3 | $2.31K | Hold |
350
| – | – | ﹤0.01% | 807 |
|
|
2024
Q2 | $2.63K | Hold |
350
| – | – | ﹤0.01% | 765 |
|
|
2024
Q1 | $3.49K | Hold |
350
| – | – | ﹤0.01% | 706 |
|
|
2023
Q4 | $3.45K | Buy |
+350
| New | +$3.45K | ﹤0.01% | 838 |
|
|
2023
Q3 | – | Sell |
-250
| Closed | -$1.87K | – | 942 |
|
|
2023
Q2 | $1.87K | Hold |
250
| – | – | ﹤0.01% | 779 |
|
|
2023
Q1 | $1.67K | Buy |
+250
| New | +$1.67K | ﹤0.01% | 831 |
|